{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:29:51Z","timestamp":1794670191763,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ijcard.2021.11.029","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T09:00:34Z","timestamp":1637312434000},"page":"62-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"349","author":[{"given":"Nso","family":"Nso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lakhdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sostanie","family":"Enoru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Most S.","family":"Munira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Radparvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Thambidorai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2021.11.029_bb0005","series-title":"Implantable Defibrillator [Internet]","author":"Ghzally","year":"2021"},{"issue":"7","key":"10.1016\/j.ijcard.2021.11.029_bb0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tcm.2015.01.015","article-title":"The implantable cardioverter-defibrillator: an update","volume":"25","author":"Miller","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0015","doi-asserted-by":"crossref","unstructured":"S.W.E. Baalman A.B.E. Quast T.F. Brouwer R.E. Knops, An overview of clinical outcomes in transvenous and subcutaneous ICD patients, Curr. Cardiol. Rep. 20 (9) (2018) 72. doi:10.1007%2Fs11886-018-1021-8.","DOI":"10.1007\/s11886-018-1021-8"},{"issue":"1","key":"10.1016\/j.ijcard.2021.11.029_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2015.08.039","article-title":"Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction","volume":"13","author":"Boersma","year":"2016","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0025","doi-asserted-by":"crossref","unstructured":"J. Kuschyk B. Rudic I. Akin M. Borggrefe S. R\u00f6ger, [The subcutaneous cardioverter-defibrillator: when less is more], Herzschrittmacherther Elektrophysiol. 26 (2) (2015) 123\u2013128 [Article in German]. doi:10.1007\/s00399-015-0378-2.","DOI":"10.1007\/s00399-015-0378-2"},{"issue":"1","key":"10.1016\/j.ijcard.2021.11.029_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2021.11.029_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.hrthm.2020.11.013","article-title":"Subcutaneous versus transvenous implantable defibrillator: an updated meta-analysis","volume":"18","author":"Rordorf","year":"2021","journal-title":"Heart Rhythm."},{"issue":"9","key":"10.1016\/j.ijcard.2021.11.029_bb0040","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/pace.13774","article-title":"Subcutaneous implantable cardioverter-defibrillator in primary and secondary prevention of sudden cardiac death: A meta-analysis","volume":"42","author":"Salas","year":"2019","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-0500-5-52","article-title":"Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis","volume":"5","author":"Neyeloff","year":"2012","journal-title":"BMC Res. Notes."},{"issue":"1","key":"10.1016\/j.ijcard.2021.11.029_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13643-019-1172-8","article-title":"Risk of bias tools in systematic reviews of health interventions: an analysis of PROSPERO-registered protocols","volume":"8","author":"Farrah","year":"2019","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0060","doi-asserted-by":"crossref","unstructured":"Z. Liu Z. Yao C. Li X. Liu H. Chen C. Gao, A step-by-step guide to the systematic review and meta-analysis of diagnostic and prognostic test accuracy evaluations, Br. J. Cancer. 108 (11, 2013) 2299\u20132303. doi:10.1038\/bjc.2013.185.","DOI":"10.1038\/bjc.2013.185"},{"key":"10.1016\/j.ijcard.2021.11.029_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2017.11.104","article-title":"Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter-defibrillators","volume":"258","author":"Boveda","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0070","doi-asserted-by":"crossref","unstructured":"T.F. Brouwer D. Yilmaz R. Lindeboom, et al., Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy, J. Am. Coll. Cardiol. 68 (19, 2016) 2047\u20132055. doi:10.1016\/j.jacc.2016.08.044.","DOI":"10.1016\/j.jacc.2016.08.044"},{"issue":"FI2","key":"10.1016\/j.ijcard.2021.11.029_bb0075","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ijcard.2021.11.029_bb0080","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijcard.2016.11.017","article-title":"A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator","volume":"228","author":"Honarbakhsh","year":"2017","journal-title":"Int. J. Cardiol"},{"key":"10.1016\/j.ijcard.2021.11.029_bb0090","doi-asserted-by":"crossref","unstructured":"R.E. Knops L.R.A. Olde Nordkamp P.-P.H.M. Delnoy, et al., Subcutaneous or transvenous defibrillator therapy, N. Engl. J. Med. 383 (6) (2020) 526\u2013536. doi:10.1056\/NEJMoa1915932.","DOI":"10.1056\/NEJMoa1915932"},{"issue":"1","key":"10.1016\/j.ijcard.2021.11.029_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","article-title":"Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study","volume":"10","author":"K\u00f6be","year":"2013","journal-title":"Heart Rhythm."},{"issue":"7","key":"10.1016\/j.ijcard.2021.11.029_bb0100","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/europace\/euy092","volume":"20","author":"Lenarczyk","year":"2018","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.ijcard.2021.11.029_bb0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/CM9.0000000000000133","article-title":"Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators","volume":"132","author":"Liang","year":"2019","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0110","doi-asserted-by":"crossref","unstructured":"A.A. Mithani H. Kath K. Hunter, et al., Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement, Europace. 20 (2) (2018) 308\u2013314. doi:10.1093\/europace\/eux026.","DOI":"10.1093\/europace\/eux026"},{"key":"10.1016\/j.ijcard.2021.11.029_bb0115","doi-asserted-by":"crossref","unstructured":"S.J. Pettit A. McLean I. Colquhoun D. Connelly K. McLeod, Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers, Pacing Clin. Electrophysiol. 36 (12, 2013) 1532\u20131538. doi:10.1111\/pace.12233.","DOI":"10.1111\/pace.12233"},{"key":"10.1016\/j.ijcard.2021.11.029_bb0120","doi-asserted-by":"crossref","unstructured":"A.B.E. Quast T.F. Brouwer K.M. Kooiman, et al., Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients, Neth. Heart J. 26 (12, 2018) 612\u2013619. doi:10.1007\/s12471-018-1186-1.","DOI":"10.1007\/s12471-018-1186-1"},{"issue":"4","key":"10.1016\/j.ijcard.2021.11.029_bb0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hrthm.2018.10.026","article-title":"Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: an analysis of current clinical practice and a comparison with transvenous ICD reimplantation","volume":"16","author":"Viani","year":"2019","journal-title":"Heart Rhythm."},{"issue":"6","key":"10.1016\/j.ijcard.2021.11.029_bb0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14740\/cr638w","article-title":"Subcutaneous implantable cardioverter defibrillators implantation without defibrillation threshold testing: a single center experience","volume":"8","author":"Al-Ghamdi","year":"2017","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0135","doi-asserted-by":"crossref","unstructured":"M. Bettin R. Larbig B. Rath, et al., Long-term experience with the subcutaneous implantable cardioverter-defibrillator in teenagers and young adults, JACC Clin. Electrophysiol. 3 (13, 2017) 1499\u20131506. doi:10.1016\/j.jacep.2017.08.017.","DOI":"10.1016\/j.jacep.2017.08.017"},{"issue":"5","key":"10.1016\/j.ijcard.2021.11.029_bb0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00392-016-1055-0","article-title":"Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems","volume":"106","author":"K\u00f6be","year":"2017","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0145","doi-asserted-by":"crossref","unstructured":"S.S. Pedersen N. Carter C. Barr, et al., Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system, Pacing Clin. Electrophysiol. 42 (12, 2019) 1541\u20131551. doi:10.1111\/pace.13828.","DOI":"10.1111\/pace.13828"},{"issue":"4","key":"10.1016\/j.ijcard.2021.11.029_bb0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.amjcard.2016.05.047","article-title":"A comparison of the quality of life of patients with an entirely subcutaneous implantable defibrillator system versus a transvenous system (from the EFFORTLESS S-ICD quality of life Substudy)","volume":"118","author":"Pedersen","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2021.11.029_bb0155","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2021.11.029_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/pace.14157","article-title":"Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction","volume":"44","author":"Chung","year":"2021","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"3","key":"10.1016\/j.ijcard.2021.11.029_bb0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.hrthm.2019.09.024","article-title":"Complications involving the subcutaneous implantable cardioverter-defibrillator: lessons learned from MAUDE","volume":"17","author":"Zeitler","year":"2020","journal-title":"Heart Rhythm."},{"issue":"9","key":"10.1016\/j.ijcard.2021.11.029_bb0170","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2021.11.029_bb0175","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/jce.15080","article-title":"Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: subcutaneous versus transvenous implantable defibrillator therapy","volume":"32","author":"Palmisano","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"6","key":"10.1016\/j.ijcard.2021.11.029_bb0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/joa3.12234","article-title":"Patient characteristics and in-hospital complications of subcutaneous implantable cardioverter-defibrillator for brugada syndrome in Japan","volume":"35","author":"Kawamura","year":"2019","journal-title":"J. Arrhythm."},{"issue":"4","key":"10.1016\/j.ijcard.2021.11.029_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study","volume":"23","author":"Gold","year":"2012","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2021.11.029_bb0190","doi-asserted-by":"crossref","unstructured":"C.-F. Chen C.-L. Jin M.-J. Liu Y.-Z. Xu, Efficacy, safety, and in-hospital outcomes of subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis and systematic review, Medicine (Baltimore). 98 (19, 2019) e15490. doi:10.1097\/md.0000000000015490.","DOI":"10.1097\/MD.0000000000015490"},{"key":"10.1016\/j.ijcard.2021.11.029_bb0195","doi-asserted-by":"crossref","unstructured":"I. Basu-Ray J. Liu X. Jia, et al., Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies, JACC Clin. Electrophysiol. 3 (13, 2017) 1475\u20131483. doi:10.1016\/j.jacep.2017.07.017.","DOI":"10.1016\/j.jacep.2017.07.017"},{"key":"10.1016\/j.ijcard.2021.11.029_bb0200","article-title":"Subcutaneous ICD: current standards and future perspective","volume":"24","author":"Kaya","year":"2019","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"4","key":"10.1016\/j.ijcard.2021.11.029_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jce.12612","article-title":"A new algorithm to reduce inappropriate therapy in the S-ICD system","volume":"26","author":"Brisben","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"8","key":"10.1016\/j.ijcard.2021.11.029_bb0210","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.hrthm.2014.04.012","article-title":"Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Gold","year":"2014","journal-title":"Heart Rhythm."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321018465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321018465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:56:21Z","timestamp":1759092981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321018465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":42,"alternative-id":["S0167527321018465"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.11.029","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}